AIC
RPRX icon

Aurora Investment Counsel’s Royalty Pharma RPRX Stock Holding History

Aurora Investment Counsel’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-35,415
Closed -$1.7M – 122
2026
Q1 		$1.7M Sell
35,415
-16,861
-32% -$738K 0.94% 54
2025
Q4 		$2.02M Sell
52,276
-1,236
-2% -$47.1K 1.06% 46
2025
Q3 		$1.89M Sell
53,512
-1,234
-2% -$44.7K 0.99% 52
2025
Q2 		$1.97M Buy
54,746
+3,422
+7% +$113K 1.04% 43
2025
Q1 		$1.6M Buy
51,324
+597
+1% +$18.9K 0.89% 57
2024
Q4 		$1.29M Buy
50,727
+286
+0.6% +$7.58K 0.71% 74
2024
Q3 		$1.43M Buy
50,441
+512
+1% +$14.2K 0.77% 66
2024
Q2 		$1.32M Buy
49,929
+6,544
+15% +$181K 0.77% 72
2024
Q1 		$1.32M Buy
43,385
+2,827
+7% +$83.3K 0.75% 78
2023
Q4 		$1.59M Buy
40,558
+2,656
+7% +$73K 1.03% 40
2023
Q3 		$1.03M Buy
37,902
+3,572
+10% +$106K 0.68% 86
2023
Q2 		$1.06M Sell
34,330
-350
-1% -$11.9K 0.68% 82
2023
Q1 		$1.25M Buy
34,680
+5,020
+17% +$186K 0.82% 72
2022
Q4 		$1.17M Sell
29,660
-1,516
-5% -$63.3K 0.81% 69
2022
Q3 		$1.25M Buy
31,176
+753
+2% +$32.2K 0.95% 46
2022
Q2 		$1.28M Buy
30,423
+484
+2% +$19.8K 0.92% 43
2022
Q1 		$1.17M Buy
29,939
+257
+0.9% +$10.1K 0.74% 76
2021
Q4 		$1.18M Buy
29,682
+6,935
+30% +$269K 0.7% 84
2021
Q3 		$822K Sell
22,747
-50
-0.2% -$1.94K 0.57% 94
2021
Q2 		$934K Buy
+22,797
New +$970K 0.65% 80

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Aurora Investment Counsel's RPRX Position: Q2 2026 in Review

Aurora Investment Counsel sold out of Royalty Pharma (RPRX) in Q2 2026, closing a stake of 35,415 shares — an estimated $1.7M sold.

Aurora Investment Counsel first reported a position in RPRX in Q2 2021 and held it in 20 quarters. The position peaked at $2.02M in Q4 2025. 646 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.

  • Aurora Investment Counsel reported no remaining Royalty Pharma position as of Q2 2026 after selling out during the quarter.
  • Aurora Investment Counsel sold 35,415 Royalty Pharma shares in Q2 2026, an estimated $1.7M.
  • Aurora Investment Counsel first reported a position in Royalty Pharma in Q2 2021 and held it in 20 quarters.
  • Aurora Investment Counsel's Royalty Pharma position peaked at $2.02M in Q4 2025.
  • 646 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.

Based on Aurora Investment Counsel's 13F filing for Q2 2026, filed 10 Aug 2026.